E-Cigarette Flavors and Frequency of E-Cigarette Use among adult Dual Users Who attempt to quit Cigarette Smoking in the United States: Longitudinal Findings from the PaTh Study 2015/16-2016/17.
Population Clinical
Cessation
Tobacco
Kasza (2021)
E-cigarette use and change in plans to quit cigarette smoking among adult smokers in the United States: Longitudinal findings from the PaTh Study 2014-2019.
Population Clinical
Cessation
Tobacco
Kasza (2022)
associations between nicotine vaping uptake and cigarette smoking cessation vary by smokers’ plans to quit: longitudinal findings from the International Tobacco Control Four Country Smoking and Vaping Surveys.
Population Clinical
Cessation
Tobacco
Kasza (2023)
Electronic Cigarette Use, Misuse, and harm.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kathuria (2022)
high School Youth and E-cigarettes: The Influence of Modified Risk Statements and Flavors on E-cigarette Packaging.
Population Clinical
Effect Of Packaging & Labelling On Perception Of Risk
Katz (2020)
Vaping Flavors and Flavor Representation: a Test of Youth Risk Perceptions, Novelty Perceptions, and Susceptibility.
Population Clinical
Perception Of Risk; Consumer Use
Flavor Appeal
Katz (2023)
Mechanisms of toxicity and biomarkers of flavoring and flavor enhancing chemicals in emerging tobacco and non-tobacco products
Individual Clinical
Biomarkers
Biomarkers Of Harm
Kaur (2018)
Immunological and toxicological risk assessment of e-cigarettes
Non-Clinical
Immunotoxicity
Kaur (2018)
Differential plasma exosomal long non-coding RNas expression profiles and their emerging role in E-cigarette users, cigarette, waterpipe, and dual smokers.
Nonclinical
Genotoxicity
In Vivo
Kaur (2020)
“Taking Up a New Problem”: Context and Determinants of Pod-Mod Electronic Cigarette Use among College Students.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Kava (2021)